Related Experiment Video
Updated: Oct 17, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Germline Variation and Somatic Alterations in Ewing Sarcoma
Mitchell J Machiela1, Thomas G P Grünewald2,3,4,5
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. mitchell.machiela@nih.gov.
Abstract:
Ewing sarcoma (EwS) is a rare bone or soft tissue tumor that occurs early in life, suggesting genetic variation is likely a major contributor to EwS risk. To date, genetic investigations have identified key somatic mutations and germline variants of importance for EwS risk. While substantial progress has been made in uncovering the genetic etiology of EwS, considerable gaps in knowledge remain. Herein, we provide a summary of methodological approaches for future genomic investigations of EwS. We anticipate that this recommended analytical framework for germline and somatic investigations, along with genomic data from growing EwS case series, will aid in accelerating new genomic discoveries in EwS and expand knowledge of the genetic architecture of this aggressive sarcoma.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Mitogens and the Cell Cycle
Abnormal Proliferation
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

